Skip to main content

Nonprofit · EIN 27-2444495

BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA

Tax-exempt · SAN FRANCISCO, CA 94127

Financials

$2.9M$7.4M2022$2.1M$9.1M2023$2.3M$7.5M2024$1.9M$6.8M2025
Revenue Expenses · by fiscal year end
Financials of BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$1,916,941$6,802,870-$4,885,929$13,199,021$231,996$12,967,025
December 31, 2024990$2,276,172$7,518,101-$5,241,929$18,325,811$287,669$18,038,142
December 31, 2023990$2,086,433$9,080,071-$6,993,638$25,667,529$2,207,386$23,460,143
December 31, 2022990 (amended)$2,859,465$7,386,966-$4,527,501$29,690,825$355,873$29,334,952
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$337,002
Program service revenue
$0
Investment income
$1,579,939
Other revenue
$0

Expenses

Grants and similar amounts paid
$4,075,908
Compensation of officers, directors and key employees
$185,000
Other salaries and wages
$148,887
Salaries, compensation and benefits (total)
$381,564
Professional fundraising fees
$0
Legal fees
$9,877
Accounting fees
$63,466
Occupancy
$33,950
Program services (functional)
$6,569,158
Management and general (functional)
$223,801
Fundraising (functional)
$9,911

Balance sheet and other

Total assets, start of year
$18,325,811
Total assets, end of year
$13,199,021
Total liabilities, end of year
$231,996
Net assets, end of year
$12,967,025
Publicly traded securities
$12,445,813
Net assets without donor restrictions
$12,967,025
Gross receipts
$1,916,941
Employees
2
Volunteers
8
Year formed
2010
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Robert V Farese Jr MDDirector
Trustee or director
1$466,613$0
Bruce Miller MDDirector
Trustee or director
1$410,000$0
Laura MiticPresident
Officer
20$225,000$0
Alexandra NicholsonDir Research Pship40$148,887$22,205
Ian Massey PhDDirector
Trustee or director
1$10,000$0
Robin Richards DonohoeBoard Chair
Trustee or director, Officer
2$0$0
Christopher DonohoeSecty/Treasurer
Trustee or director, Officer
0.5$0$0
Roy Richards JrDirector
Trustee or director
1$0$0
Williamson Bradford MDDirector
Trustee or director
0.5$0$0
Karen Chen PhDDirector
Trustee or director
1$0$0
990 for the year ended December 31, 2024: 10 people
NameTitleHours / weekCompensationFrom related orgsOther / benefits
Robert V Farese Jr MDDirector
Trustee or director
1$477,613$0$0
Bruce Miller MDDirector
Trustee or director
1$410,000$0$0
Laura MiticPresident
Officer
20$145,000$148,016$0
Alexandra NicholsonDir Research Pship40$138,833$0$19,052
Ian Massey PhDDirector
Trustee or director
1$10,000$0$0
Robin Richards DonohoeBoard Chair
Trustee or director, Officer
2$0$0$0
Christopher DonohoeSecty/Treasurer
Trustee or director, Officer
0.5$0$0$0
Roy Richards JrDirector
Trustee or director
1$0$0$0
Williamson Bradford MDDirector
Trustee or director
0.5$0$0$0
Karen Chen PhDDirector
Trustee or director
1$0$0$0
990 for the year ended December 31, 2023: 11 people
NameTitleHours / weekCompensationFrom related orgsOther / benefits
Rodney PerlmanPresident40$343,000$0$77,118
Bruce Miller MDDirector
Trustee or director
1$410,000$0$0
Robert V Farese Jr MDDirector
Trustee or director
1$367,193$0$0
Laura MiticPresident
Officer
20$101,728$136,319$0
Alexandra NicholsonAssoc Dir Rsrch40$128,000$0$13,011
Ian Massey PhDDirector
Trustee or director
1$10,000$0$0
Robin Richards DonohoeBoard Chair
Trustee or director, Officer
2$0$0$0
Christopher DonohoeSecty/Treasurer
Trustee or director, Officer
0.5$0$0$0
Roy Richards JrDirector
Trustee or director
0.5$0$0$0
Williamson Bradford MDDirector
Trustee or director
0.5$0$0$0
Karen Chen PhDDirector
Trustee or director
1$0$0$0
990 for the year ended December 31, 2022: 11 people
NameTitleHours / weekCompensationFrom related orgs
Bruce Miller MDDirector
Trustee or director
4$410,000$0
Rodney Pearlman PhDPresident
Officer
40$368,000$0
Robert V Farese Jr MDDirector
Trustee or director
4$321,891$0
Laura Mitic PhdChief Scientific10$57,750$136,319
Alexandra NicholsonAssoc Dir Rsrch40$121,888$0
Ian Massey PhDDirector
Trustee or director
4$10,000$0
Robin Richards DonohoeBoard Chair
Trustee or director, Officer
4$0$0
Christopher DonohoeSecty/Treasurer
Trustee or director, Officer
4$0$0
Roy Richards JrDirector
Trustee or director
4$0$0
Williamson Bradford MDDirector
Trustee or director
4$0$0
Karen Chen PhDDirector
Trustee or director
4$0$0

Address and contacts

Address (IRS master file)
236 WEST PORTAL AVE PMB 294, SAN FRANCISCO, CA 94127-1423
In care of
% CONSORTIUM FOR FRONTOTEMPORAL
Principal officer (990 for 2025)
Robin Richards Donohoe, 236 West Portal Ave 294, San Francisco, CA 94127
Signed the 990
Laura Mitic, President
Phone
(415) 626-1501
Return prepared by
REGALIA BERGER & BERGER CPAS

California records

California keeps its own records of charities and corporations. Search them by EIN 27-2444495 or by the name BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

frontal lobe of the brain and may extend back to the temporal lobe. FTD is the second most common early-onset dementia after Alzheimer's disease.

990 for the year ended December 31, 2025

Program accomplishments

  • The Bluefield Project is an effort to find a treatment or cure for frontotemporal dementia (FTD) by funding FTD-related research. By privately funding basic, translational and clinical FTD-related research, the donor group that established The Bluefield Project has significantly increased the number of labs studying FTD. THE BLUEFIELD RESEARCH CONSORTIUM, FUNDED BY THE BLUEFIELD PROJECT, APPLIES A BUSINESS MODEL TO RESEARCH BY INCENTIVIZING THE SHARING OF DATA AND REAGENTS, THEREBY ACCELERATING DISCOVERY. FTD ENCOMPASSES A GROUP OF COMPLEX NEURODEGENERATIVE DISEASES CHARACTERIZED BY PROGRESSIVE DETERIORATION OF THE FRONTOTEMPORAL LOBES AND RESULTANT LOSS OF DECISION-MAKING ABILITIES AND CONTROL OF BEHAVIOR, EMOTION, AND LANGUAGE.
    Expenses $6,569,158 · grants $4,075,908

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
27-2444495
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2010
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$13,199,021
Income (IRS master file)
$1,916,941

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$1,916,941$6,802,870$13,199,021XML
990December 2024$2,276,172$7,518,101$18,325,811XML
990December 2023$2,086,433$9,080,071$25,667,529XML
990December 2022$2,859,465$7,386,966$29,690,825XML
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 27-2444495).

Questions about BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA

What is the EIN of BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA?
The employer identification number (EIN) of BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA is 27-2444495.
Is BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2010.
Are donations to BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA?
The 990 for the year ended December 31, 2025 names Robin Richards Donohoe.
Who are the officers and directors of BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA?
The 990 for the year ended December 31, 2025 lists 10 people; 5 received compensation from the organization, the highest $466,613 (Robert V Farese Jr MD, Director).
How much revenue does BLUEFIELD PROJECT TO CURE FRONTOTEMPORAL DEMENTIA have?
On its 990 for the year ended December 31, 2025 it reported revenue of $1,916,941, expenses of $6,802,870 and total assets of $13,199,021 at year end.

Other nonprofits in SAN FRANCISCO

All nonprofits in SAN FRANCISCO · California · Voluntary health associations and medical disciplines